Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 13/02/2024

Debbie Rigby takes a look at the latest in research news Management of type 2 diabetes in patients with frailty Newer antihyperglycemic agents such as glucagonlike peptide-1 receptor agonists (GLP1-RAs), dipeptidyl peptidase 4 inhibitors (DPP4Is), and sodium-glucose cotransporter-2 inhibitors (SGLT2Is) are therapeutic options for older patients due to these agents’ low hypoglycaemic risk and benefits

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Ozempic shortage to continue in 2025

Appalled at this given the flooding of Wegovy at the wholesalers the past several months. Add to that the wasted…

Greg Willday

Ozempic shortage to continue in 2025

Believing any of the “shortage to end by” dates is like believing that Amcal or DDS data will be “ring-fenced”…

John Smith

Patients back scope expansion

It’s OK Michael…we’ll have a MedAdvisor script to follow, so no need for any training at all really. In fact,…

John Smith

Patients back scope expansion

Maybe I’m missing something (my statistics lectures were a while ago now haha) but 100 people representing “the Australian people”…

John Smith

Research Roundup

Previous Aurora Cannabis acquires MedReleaf

Next ‘Circumvention of the rules’ leads to pharmacist’s tribunal hearing

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Aurora Cannabis acquires MedReleaf

Next ‘Circumvention of the rules’ leads to pharmacist’s tribunal hearing

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.